KIMS Shares Make Strong Debut Listing at a 22% Premium

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  
  • Home
  • Views On News
  • Jun 28, 2021 - KIMS Shares Make Strong Debut Listing at a 22% Premium

KIMS Shares Make Strong Debut Listing at a 22% Premium

Jun 28, 2021

Shares of Krishna Institute of Medical Sciences (KIMS) made a strong debut on the stock exchanges today.

Shares listed at Rs 1,008.90 on the BSE, a 22.29% premium over its issue price of Rs 825. On the NSE, the stock listed at Rs 1,009, up 22.30% from issue price.

Post listing, KIMS shares soared to Rs 1,059.

However, shares of the company pared some of its gains to end at Rs 996.

The company now commands a marketcap of Rs 79.7 bn.

KIMS IPO gets Ashish Kacholia interested

Renowned investor Ashish Kacholia had placed an application for over 2 m shares, worth about Rs 1.8 bn in the initial public offer (IPO) of KIMS Hospitals.

Ashish Kacholia is known for his bets on mid-cap and small-cap stocks.

Birlasoft, Mastek, Poly Medicure, Apollo Tricoat Tubes, Phillips Carbon, and Caplin Point are some of his top holdings.

The Rs 21.4 bn IPO was open for subscription between 16 June and 18 June. This included a little over Rs 9.6 bn, that was mobilised from anchor investors.

--- Advertisement ---
[Alert] Sell These 3 Stocks Immediately

These 3 stocks are ticking time bombs in your portfolio.

It is very likely that you could be owning these 3 overvalued...

fundamentally weak... ready to crash stocks... in your portfolio today.

Because many stock brokers have painted rosy pictures of these stocks. But the reality is starkly different.

If the market crashes, then these stocks could wipe out your wealth.

You should get rid of these stocks as soon as possible.

We are going to reveal details of these 3 landmines at our upcoming special event at 5 pm on September 24.

You can click here to sign-up. It's free

The IPO saw strong response as the offer received bids for 55,655,046 shares compared with 14,413,073 shares on offer.

The quota reserved for qualified institutional buyers (QIBs) was subscribed 5.26 times while the one for non-institutional investors received 1.89 times bids.

Retail investors also showed strong participation as the quota reserved for them was subscribed to 2.89 times.

Grey market premium holds

Ahead of its listing, KIMS shares were trading at a premium of Rs 110 or at a price of Rs 935 in the grey market.

Shares were expected to list at premium to its issue price given the strong response seen from investors.

The strong listing can be attributed to a decent performance last week by Shyam Metalics and Sona Comstar.

Last week, Shyam Metalics listed at Rs 380, a 24.2% premium over its issue price of Rs 306.

Meanwhile, Sona BLW Precision Forgings listed at Rs 302.4, a 3.9% premium to issue price of Rs 291 per share. Later in the day, shares of the company were locked in the 20% upper circuit on the back of strong demand.

On top of all this, market sentiment also had a role to play. Benchmark indices BSE Sensex and NSE Nifty opened at record highs today before paring gains.

Indian share markets rose to record highs tracking the positive US stock markets and mixed Asian shares.

Market experts are suggesting KIMS shareholders to hold the stock, showing emphasis on the company's financials and the fact that HNI and mutual fund houses are expected to buy stake in the company from the secondary market.

Covid Impact

Despite a surge in topline and bottomline, KIMS said that the Covid-19 pandemic had an adverse impact on its operations.

In March 2020 and more so in April 2020, it witnessed a substantial decline in in-patient and out-patient volumes.

REVEALED: 3 "Super Smallcaps" You Didn't Know About

When compared to February 2020, its inpatient volumes fell by more than half in April 2020.

This was because some patients were reluctant to visit hospitals due to a perceived notion of increased risk of infection.

Further, the dependence of KIMS on hospitals in Hyderabad is also a concern.

The company also competes with strong peers such as Apollo Hospitals, Fortis Healthcare, and Aster DM Healthcare, among others.

About Krishna Institute of Medical Sciences

Incorporated in 1973, Krishna Institute of Medical Sciences (KIMS) is one of the largest healthcare groups in Andhra Pradesh and Telangana.

KIMS provides multi-disciplinary healthcare services with a key focus on primary, secondary, and tertiary care in tier 2-3 cities.

--- Advertisement ---
INSIDER SECRET: An Astonishingly Easy Way to Pile Up Potentially 40-60% Gains in Just 1 Year

India's most well-connected trader with over 35 years of experience just confessed...

"This Lucrative Market Segment Could Leapfrog Over Nifty in The Next 12-16 Months"

... thanks to a massive and irreversible mega-trend fueling its growth!

In fact, he and his partner have already identified 2 spectacular stocks from this segment... which are ready to rake in potentially 40-60% gains in just 1 year... and make you big, fat profits!

The best part of them all...

Their Details Are Packed in This Special Report (Discover How to Claim it for Free)

The company offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, and mother & child care.

As of 31 March 2021, it operates through 9 multi-specialty hospitals under the brand name of 'KIMS Hospitals' with an aggregate bed capacity of 3,064 including over 2,500 operational beds.

After the listing of KIMS shares at BSE and NSE, promoters' holding in the company now stands at 38.84%, which was at 46.81% before the issue listing.

It remains to be seen how the stock performs going forward.

For a sector overview, read our pharmaceuticals sector report.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

Disclaimer: This article is for information purposes only. It is not a stock recommendation and should not be treated as such. Learn more about our recommendation services here...

Equitymaster requests your view! Post a comment on "KIMS Shares Make Strong Debut Listing at a 22% Premium". Click here!


More Views on News

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Glenmark Life Sciences Makes Lacklustre Debut. Shares List At 4% Premium (Views On News)

Aug 6, 2021

Glenmark Life Sciences' IPO had received strong response from investors as the offer was subscribed 44.17 times.

More Views on News

Most Popular

A Complete Guide for Beginners on How to Invest in IPOs

As an investor, you must have endeavoured to find a suitable opportunity for investing in IPOs. But do you know what is an IP...

5 Small-cap Stocks with Zero Debt (Views On News)

Sep 3, 2021

In this article, you will get a list of 5 debt free small-cap companies that are worth tracking.

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore (Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

Put the Odds in Your Favour to Find Smallcap Multibaggers (Profit Hunter)

Sep 3, 2021

A handy checklist to find multibagger smallcaps.


Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Sep 16, 2021 (Close)